Lv2
178 积分 2023-12-19 加入
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis
20天前
已完结
A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study
20天前
已完结
Managing side effects of JAK inhibitors for myelofibrosis in clinical practice
1个月前
已完结
Myofibroblasts and mechano-regulation of connective tissue remodelling
1个月前
已完结
The role of pegfilgrastim in mobilization of hematopoietic stem cells
2个月前
已完结
G-CSF Alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment
2个月前
已完结
How to manage poor mobilisers
2个月前
已完结
Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
2个月前
已完结
Hematopoietic Stem Cell Mobilization: A Clinical Protocol
2个月前
已完结
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data
2个月前
已完结
皖公网安备34019202002308
